These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8952756)

  • 1. Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment.
    Galli M; Finazzi G; Barbui T
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():24-7. PubMed ID: 8952756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory thrombocytopenia in antiphospholipid syndrome.
    Sharma B; Kapoor S; Malaviya AN
    J Assoc Physicians India; 2005 Feb; 53():147-9. PubMed ID: 15847038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Italian Registry of Antiphospholipid Antibodies.
    Finazzi G
    Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological involvement in antiphospholipid antibodies syndrome (APS).
    Amoroso A; Mitterhofer AP; Ferri GM; Galluzzo S; Vadacca M; Afeltra A
    Eur Rev Med Pharmacol Sci; 1999; 3(5):205-9. PubMed ID: 11075618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia.
    Hoppensteadt DA; Walenga JM
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):1-18, v. PubMed ID: 18207062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding in the antiphospholipid syndrome.
    Forastiero R
    Hematology; 2012 Apr; 17 Suppl 1():S153-5. PubMed ID: 22507807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematologic manifestations of the antiphospholipid syndrome.
    Uthman I; Godeau B; Taher A; Khamashta M
    Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
    Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
    Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Budd-Chiari syndrome and severe thrombocytopenia in a patient with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome].
    Duarte C; Couto M; Inês L; Malcata A
    Acta Reumatol Port; 2007; 32(2):175-80. PubMed ID: 17576398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.